Covington Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-250
Closed -$7K 1067
2021
Q2
$7K Buy
+250
New +$4.91K ﹤0.01% 822

Covington Capital Management's TBIO Position: Q3 2021 in Review

Covington Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 250 shares — an estimated $7K sold.

Covington Capital Management first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $7K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Covington Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Covington Capital Management sold 250 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $7K.
  • Covington Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Covington Capital Management's Translate Bio, Inc. Common Stock position peaked at $7K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Covington Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.